Accueil>>Peptides>>[Sar1, Ile8]-Angiotensin II

[Sar1, Ile8]-Angiotensin II

Catalog No.GC35025

[Sar1, Ile8]-Angiotensine II est un peptide qui a de multiples effets sur le muscle lisse vasculaire, y compris la contraction des artères normales et l'hypertrophie ou l'hyperplasie des cellules cultivées ou des vaisseaux malades.

Products are for research use only. Not for human use. We do not sell to patients.

[Sar1, Ile8]-Angiotensin II Chemical Structure

Cas No.: 37827-06-8

Taille Prix Stock Qté
10mg
102,00 $US
En stock
50mg
389,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Video Related Products

[Sar1, Ile8]-Angiotensin II is a peptide that has multiple effects on vascular smooth muscle, including contraction of normal arteries and hypertrophy or hyperplasia of cultured cells or diseased vessels.

Angiotensin II has multiple effects on vascular smooth muscle, including contraction of normal arteries and hypertrophy or hyperplasia of cultured cells or diseased vessels. Angiotensin II activates both the NADPH and NADH oxidases, and stimulates superoxide anion formation in vascular smooth muscle cells[1].

[1]. Griendling KK, et al. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 1994 Jun;74(6):1141-8.

Avis

Review for [Sar1, Ile8]-Angiotensin II

Average Rating: 5 ★★★★★ (Based on Reviews and 33 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for [Sar1, Ile8]-Angiotensin II

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.